Ann: Hepatitis B Virus Program Update, page-13

First 13 Last

Share
Profile

Follow
GiddyYup

4,052 Posts.

637

25/06/25

09:00

Post #: 79556063
Share

Originally posted by Davisite: ↑

Releasing this as price sensitive is frankly embarrassing. This is a totally standard dose ranging study that is done before every mouse study of a drug and takes a couple of weeks. These sort of mouse studies cost between $5 and $10k when outsourced to a CRO (contract research organisation). It is just slightly above announcing you dissolved your drug in a saline solution.

Assuming BIT have a new candidate drug for HBV, they will need to spend between $5 and $7 million and around 2 year to get any such candidate to be ready to dose a human (i.e. the CMC and non-clinical animal studies). I will leave it to others to decide if raising this sort of capital is likely for BIT. The muted response from the market suggests nobody does.

Expand

Given the current SP they would need to issue a minimum of 5 billion new shares just to raise the bottom end of your cost estimate. Years of waiting for them to actually do anything. Endless delays which they are famous for.

I just don't think most of us would live long enough to see what BS story they could come up with at the end of this.

BIT Price at posting: 0.2¢ Sentiment: None Disclosure: Not Held
4 Upvote

0 Great analysis

Reply

Top Stories

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

BOE

Boss extends June win streak with boosted Alta Mesa extraction rates

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

First 13 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 0.2¢		Change 0.000(0.00%)		Mkt cap ! $2.654M

Open	High	Low	Value	Volume
0.2¢	0.2¢	0.2¢	$184	92K

Buyers (Bids)

No.	Vol.	Price($)
60	36594676	0.2¢

Sellers (Offers)

Price($)	Vol.	No.
0.3¢	14236347	24

View Market Depth

No.	Vol.	Price($)
59	36544676	0.002
32	65031001	0.001
0	0	0.000
0	0	0.000
0	0	0.000

Price($)	Vol.	No.
0.003	14236347	24
0.004	12820969	17
0.005	6684000	5
0.006	1200000	2
0.007	1084188	2

Last trade - 11.37am 27/06/2025 (20 minute delay)

BIT (ASX) Chart

Ann: Hepatitis B Virus Program Update, page-13

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Australia’s gas crisis is here – and dying coal plants aren’t helping

Boss extends June win streak with boosted Alta Mesa extraction rates

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Hepatitis B Virus Program Update, page-13

Top Stories

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Australia’s gas crisis is here – and dying coal plants aren’t helping

Boss extends June win streak with boosted Alta Mesa extraction rates

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News